Skip to main content
OpenTrials
Completed

NCT Number: NCT01145144

Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–42 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Meir Medical center IVF unit, Kfar Saba, Israel

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • previous poor response to ovarian stimulation in IVF.

Exclusion criteria

  • patients over the age of 42
  • patients who received DHEA at any time.

Treatment and study plan

dehydroepiandrosterone crystalline fine powder

Drug

Primary outcomes

  1. peak estradiol level.

  2. number of retrieved oocytes.

  3. Embryos that were graded as a top quality (according to the number of cells and percent of fragmentation)

  4. number of embryos reserved for transfer.

Secondary outcomes

  1. pregnancy rate.

  2. live birth rate.

Sponsors and collaborators

Lead sponsor

Meir Medical Center

Other

Registry information

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Jun 16, 2010
Registry last updated
Jun 16, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.